GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (OTCPK:MROPF) » Definitions » Capex-to-Operating-Income

MROPF (MicroPort CardioFlow Medtech) Capex-to-Operating-Income : 0.00 (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort CardioFlow Medtech Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

MicroPort CardioFlow Medtech's Capital Expenditure for the six months ended in Dec. 2024 was $-21.01 Mil. Its Operating Income for the six months ended in Dec. 2024 was $-12.43 Mil.

GuruFocus do not calculate Capex-to-Operating-Income if the Operating Income is negative.

MicroPort CardioFlow Medtech Capex-to-Operating-Income Historical Data

The historical data trend for MicroPort CardioFlow Medtech's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort CardioFlow Medtech Capex-to-Operating-Income Chart

MicroPort CardioFlow Medtech Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capex-to-Operating-Income
Get a 7-Day Free Trial - - - - -

MicroPort CardioFlow Medtech Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of MicroPort CardioFlow Medtech's Capex-to-Operating-Income

For the Medical Devices subindustry, MicroPort CardioFlow Medtech's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MicroPort CardioFlow Medtech's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort CardioFlow Medtech's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where MicroPort CardioFlow Medtech's Capex-to-Operating-Income falls into.


;
;

MicroPort CardioFlow Medtech Capex-to-Operating-Income Calculation

MicroPort CardioFlow Medtech's Capex-to-Operating-Income for the fiscal year that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-21.754) / -21.931
=N/A

MicroPort CardioFlow Medtech's Capex-to-Operating-Income for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-21.009) / -12.434
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

MicroPort CardioFlow Medtech  (OTCPK:MROPF) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.

MicroPort CardioFlow Medtech Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of MicroPort CardioFlow Medtech's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.

MicroPort CardioFlow Medtech Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort CardioFlow Medtech Corp (OTCPK:MROPF) » Definitions » Capex-to-Operating-Income
Comparable Companies
HKSE:01696 HKSE:06669 HKSE:09877 HKSE:02235 HKSE:02216 HKSE:02500 HKSE:06922 HKSE:06609 HKSE:09996 HKSE:02170 ABT BSX SYK MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA STE
Traded in Other Exchanges
02160:Hong Kong 72X:Germany
Address
No. 1601 Zhangdong Road, Zhangjiang Hi-Tech Park, Pudong New District, Shanghai, CHN, 201203
Website
https://www.cardioflowmedtech.com
MicroPort CardioFlow Medtech Corp is a medical device company in China focusing on the research, development, and commercialization of transcatheter and surgical solutions for valvular heart diseases. The company's product portfolio consists of three products VitaFlow, VitaFlow Liberty, and Alwide Plus, and various TAVI products, TMV products, TTV products, surgical valve products, and procedural accessories. Geographically, it derives a majority of its revenue from China.